R. Baker

发表

The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy

H. Masur, A. Moorman, J. Grubb, 2006, AIDS.

Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort.

J. Chmiel, K. Buchacz, A. Moorman, 2006, Journal of acquired immune deficiency syndromes.

Failure to vaccinate against whooping cough.

R. Baker, D. Stevens, S. Hands, 1986, Archives of disease in childhood.

Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.

K. Buchacz, J. Brooks, Christine N Dao, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study

J. Chmiel, K. Lichtenstein, K. Buchacz, 2010, AIDS.

Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study

John T Brooks, J. Chmiel, A. Moorman, 2006, Journal of acquired immune deficiency syndromes.

Short-term safety and tolerability of didanosine combined with high- versus low-dose tenofovir disproxil fumarate in ambulatory HIV-1-infected persons.

C. Armon, A. Moorman, K. Wood, 2006, AIDS patient care and STDs.

Hepatitis A and B vaccination practices for ambulatory patients infected with HIV.

A. Moorman, K. Wood, S. Holmberg, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.

A. Moorman, K. Wood, S. Holmberg, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increased Body Mass Index Does Not Alter Response to Initial Highly Active Antiretroviral Therapy in HIV-1-Infected Patients

K. Buchacz, A. Moorman, K. Wood, 2006, Journal of acquired immune deficiency syndromes.

Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999–2007

J. Ward, K. Buchacz, A. Moorman, 2011, Journal of viral hepatitis.

Renal Function in Tenofovir-Exposed and Tenofovir-Unexposed Patients Receiving Highly Active Antiretroviral Therapy in the HIV Outpatient Study

J. Chmiel, K. Buchacz, A. Moorman, 2007, Journal of the International Association of Physicians in AIDS Care.

Antiretroviral Regimen Durability and Success in Treatment-Naive and Treatment-Experienced Patients by Year of Treatment Initiation, United States, 1996–2011

John T Brooks, J. Chmiel, C. Armon, 2016, Journal of acquired immune deficiency syndromes.

CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000–2009

C. Armon, K. Buchacz, J. Brooks, 2011, AIDS research and treatment.

Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005

K. Buchacz, A. Moorman, K. Wood, 2008, AIDS.

Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999–2008

J. Chmiel, D. Ward, K. Buchacz, 2012, AIDS research and treatment.

Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment

J. Chmiel, K. Buchacz, J. Brooks, 2011, AIDS.

Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us

J. Chmiel, K. Lichtenstein, K. Buchacz, 2012, Antiviral therapy.

Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantification

D. Ward, A. Moorman, K. Wood, 2002, AIDS.

Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?

C. Armon, K. Buchacz, J. Brooks, 2014, AIDS patient care and STDs.

Changes in the Use of HIV Antiretroviral Resistance Testing in a Large Cohort of U.S. Patients, 1999 to 2006

K. Buchacz, J. Brooks, B. Young, 2009, Journal of acquired immune deficiency syndromes.

HIV Genotypic Resistance Testing to Optimize Antiretroviral Prescribing: Is There Room for Improvement?

John T Brooks, Richard Novak, A. Moorman, 2007, Antiviral therapy.

Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)‐exposed and TDF‐unexposed HIV‐infected out‐patients receiving highly active antiretroviral therapy

K. Buchacz, A. Moorman, R. Baker, 2006, HIV medicine.

Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999–2007

K. Buchacz, A. Moorman, J. Brooks, 2011, Journal of viral hepatitis.

25% of HIV positive individuals not treated according to Federal guidelines.

R. Baker, 1998, BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation.